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Oxidative stressThe role of the main intracellular energy sensor adenosine monophosphate (AMP)-activated protein kinase
(AMPK) in the induction of autophagic response and cell death was investigated in SH-SY5Y human
neuroblastoma cells exposed to the dopaminergic neurotoxin 6-hydroxydopamine (6-OHDA). The induction
of autophagy in SH-SY5Y cells was demonstrated by acridine orange staining of intracellular acidic vesicles,
the presence of autophagosome- and autophagolysosome-like vesicles conﬁrmed by transmission electron
microscopy, as well as by microtubule‐associated protein 1 light‐chain 3 (LC3) conversion and p62 degradation
detected by immunoblotting. 6-OHDA induced phosphorylation of AMPK and its target Raptor, followed by the
dephosphorylation of the major autophagy inhibitor mammalian target of rapamycin (mTOR) and its substrate
p70S6 kinase (S6K). 6-OHDA treatment failed to suppress mTOR/S6K phosphorylation and to increase LC3
conversion, p62 degradation and cytoplasmatic acidiﬁcation in neuroblastoma cells in which AMPK expression
was downregulated by RNA interference. Transfection of SH-SY5Y cells with AMPK or LC3β shRNA, as well as
treatment with pharmacological autophagy inhibitors suppressed, while mTOR inhibitor rapamycin potentiated
6-OHDA-induced oxidative stress and apoptotic cell death. 6-OHDA induced phosphorylation of p38 mitogen-
activated protein (MAP) kinase in an AMPK-dependent manner, and pharmacological inhibition of p38 MAP
kinase reduced neurotoxicity, but not AMPK activation and autophagy triggered by 6-OHDA. Finally, the
antioxidant N-acetyl cysteine antagonized 6-OHDA-induced activation of AMPK, p38 and autophagy. These data
suggest that oxidative stress-mediated AMPK/mTOR-dependent autophagy and AMPK/p38-dependent
apoptosis could be valid therapeutic targets for neuroprotection.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Parkinson's disease (PD) is a neurodegenerative disorder character-
ized by the preferential loss of the dopaminergic neurons of the
substantia nigra, part of the brain that controls muscle movement,
resulting in bradykinesia, rigidity and resting tremors [1]. Even though
the neurochemical defects and neuropathological characteristics of this
disease are well deﬁned, its etiology is still unknown. One of the most, AMP-activated protein kinase;
, extracellular signal-regulated
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get of rapamycin; MTT, 3-(4,5-
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vic), buajk@yahoo.com
l rights reserved.common neurotoxins used to selectively kill dopaminergic and norad-
renergic neurons in experimental models of PD both in vivo and in vitro
is oxidopamine, also known as 6-hydroxydopamine (6-OHDA) [2].
6-OHDA is a hydroxylated analogue of the natural neurotransmitter
dopamine, and its presence has been demonstrated in both rat and
human brain [3,4]. Neurotoxic action of oxidopamine is mainly
mediated by reactive oxygen species (ROS) such as hydrogen
peroxide, superoxide and hydroxyl radicals generated by its intra
or extracellular auto-oxidation [5]. Hydrogen peroxide, which is
also generated by monoamine oxidase activity in 6-OHDA treated
neurons, further reacts with iron and produces highly reactive
hydroxyl radical [2]. The oxidative stress induces lipid peroxidation,
cytoskeleton disorganization and DNA defects, which together with the
direct inhibition of the mitochondrial respiratory chain by 6-OHDA
eventually results in apoptotic and/or necrotic neuronal cell death [2].
Macroautophagy (referred to hereafter as autophagy) is a catabolic
process involving the degradation of the cell's own components
in organelles called autophagolysosomes [6]. It begins with the
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somes, followed by their fusion with lysosomes and formation of
autophagolysosomes, in which the internal content is degraded by acidic
lysosomal hydrolases. While the physiological role of autophagy is to
eliminate unused long-lived proteins and damaged organelles, it also acts
as a survival mechanism in metabolic or hypoxic stress [7]. On the other
hand, when it is extensive, activated inappropriately or in cells which are
unable to die by apoptosis, it can function as an alternative cell-death
pathway (programmed cell death type II) [8–10]. Accordingly, it has been
proposed that autophagy is involved in the maintenance of neuronal
homeostasis, with either defective or excessive autophagy contributing to
the neuronal loss in ischemic brain injury and neurodegenerative
disorders, including PD [11,12]. The expression and activation of
numerous Atg proteins required for autophagic response are suppressed
by mammalian target of rapamycin (mTOR), a serine/threonine kinase
that acts as a major negative regulator of autophagy [13,14]. One of the
principal regulators ofmTOR activation is AMP-activated protein kinase
(AMPK), the main energy-saving intracellular enzyme activated in
various stress conditions by the increase in AMP/ATP ratio [15]. AMPK-
mediated phosphorylation of its target Raptor and consequent
inhibition of mTOR induce autophagy [16], causing either cytotoxicity
or cytoprotection in a context-dependent manner [17–20]. AMPK-
dependent autophagy might play a dual role also in the neuronal
survival, being neuroprotective in amyloid-beta accumulation [21] and
deleterious in tributyltin chloride neurotoxicity [22].
Oxidopamine has been found to induce autophagy in neurons both in
vitro and in vivo [23–27], and it seems that autophagy might be involved
in 6-OHDA-induced neuronal damage in vivo [25,27]. However, the
mechanisms underlying these phenomena have not been extensively
elucidated. More speciﬁcally, no study to our knowledge has examined
the role of AMPK/mTOR signaling axis in 6-OHDA-triggered neuronal
autophagy and neurotoxicity. In the present study, we investigate in
more detail the role of the AMPK/mTOR signaling pathway in 6-OHDA-
induced autophagy in SH-SY5Y neuron-like cells, as well as the
contribution of the autophagic response to the in vitro neurotoxicity
of 6-OHDA.
2. Materials and methods
2.1. Cells and reagents
All reagents were purchased from Sigma (St. Louis, MO), unless
stated otherwise. The human neuroblastoma cell line SH-SY5Y
(American Type Culture Collection) was grown at 37 °C in a humidiﬁed
atmospherewith 5% CO2, in aModiﬁed EagleMedium+F12 cell culture
medium (1:1) (PAA Laboratories, Pasching, Austria) supplemented
with 10% fetal calf serum, 2 mM L-glutamine, nonessential amino acids
and penicillin/streptomycin. The cells were prepared for experiments
using the conventional trypsinization procedurewith trypsin/EDTA and
incubated in 96-well ﬂat-bottomplates (1.5×104 cells/well) for the cell
viability assessment, 24-well plates (1.2×105 cells/well) for the ﬂow
cytometric analysis, or 60 mm cell culture plates (1×106 cells) for
the Western blotting. Cells were rested for 24 h and then treated with
6-OHDA in the absence or presence of the antioxidant N-acetylcysteine,
mTOR inhibitor rapamycin, p38 inhibitor SB203580 or the autophagy
inhibitors baﬁlomycin A1, chloroquine, NH4Cl, 3-methyladenine and
wortmannin, as described in Results and ﬁgure legends.
2.2. Cell viability assays
Crystal violet staining of adherent, viable cells, measurement of
mitochondria-dependent reduction of 3-(4,5-dimethylthiazol-2-yl)-2,
5-diphenyltetrazoliumbromide (MTT) to formazan as an indicator of the
mitochondrial dehydrogenase activity, and the release of intracellular
enzyme lactate dehydrogenase (LDH) as a marker of cell membrane
damage, were used to determine cell viability exactly as previouslydescribed [28]. The results were presented as % of the crystal violet/
MTT absorbance obtained in untreated cells (100%). The percentage of
dead cells was determined by LDH assay using the following formula:
[(E−C)/(T−C)]×100, where E is the experimental absorbance of
treated cells, C is the control absorbance of untreated cells, and T is the
absorbance corresponding to the maximal (100%) LDH release of Triton
X-100-lysed cells.
2.3. Apoptosis analysis and caspase activation
Apoptotic cell death was analyzed by double staining with annexin
V-FITC and PI, in which annexin V binds to early apoptotic cells with
exposed phosphatidylserine, while PI labels the late apoptotic/necrotic
cells with membrane damage. Staining was performed according to the
instructions by the manufacturer (BD Pharmingen, San Diego, CA). A
green/red (FL1/FL2) ﬂuorescence of annexin/PI− and PI-stained cells was
analyzed with FACSCalibur ﬂow cytometer (BD, Heidelberg, Germany).
The numbers of viable (annexin−/PI−), apoptotic (annexin+/PI−) and
late apoptotic/necrotic (annexin+/PI+) cells were determinedwith a Cell
Quest Pro software (BD). Activation of caspases was measured by ﬂow
cytometry after labeling the cells with a cell-permeable, FITC-conjugated
pan-caspase inhibitor (ApoStat; R&D Systems, Minneapolis, MN) accord-
ing to themanufacturer's instructions. The increase in green ﬂuorescence
(FL1) as a measure of caspase activity was determined using FACSCalibur
ﬂow cytometer.
2.4. Reactive oxygen species (ROS) determination
Intracellular production of ROS was determined by measuring the
intensity of green ﬂuorescence emitted by the redox-sensitive dye
dihydrorhodamine 123 (DHR; Invitrogen, Paisley, UK). The produc-
tion of superoxide was measured using superoxide-selective ﬂuoro-
chrome dihydroethidium (DHE; Invitrogen, Paisley, UK). DHR (2 μM)
was added to cell cultures at the beginning of treatment, while DHE
(20 μM) was incubated with the cells for the last 30 min of the
treatment. At the end of incubation, cells were detached by
trypsinization, washed in PBS, and the mean intensity of green (FL1,
DHR) or red (FL2, DHE) ﬂuorescence, corresponding to total ROS or
superoxide levels, respectively, was determined using a FACSCalibur
ﬂow cytometer.
2.5. Intracellular detection of acidic vesicles and autophagic vacuoles
The acidic vesicles were visualized by acridine orange staining.
After incubation, cells were washed with PBS and stained with
acridine orange (1 μM) for 15 min at 37 °C. Subsequently, cells were
washed and analyzed under the inverted ﬂuorescent microscope.
Autophagolysosomes and lysosomes appeared as red ﬂuorescent
cytoplasmic vesicles, while nuclei were stained green. Alternatively,
acridine orange-stained cells were trypsinized, washed and analyzed
on a FACSCalibur ﬂow cytometer using Cell Quest Pro software.
Accumulation of acidic vesicles was quantiﬁed as red/green ﬂuores-
cence ratio (mean FL3/FL1). The presence of double-membraned
autophagosomes was evaluated by transmission electron microscopy
(TEM). The trypsinized cells were ﬁxed with 2.5% glutaraldehyde in
PBS, followed by 2% OsO4. After dehydration, thin sections were
stained with uranyl acetate and lead citrate for observation under a
Morgagni 268(D) electron microscope (FEI, Hillsboro, OR).
2.6. Immunoblot analysis
The cells were lysed in lysis buffer (30 mM Tris–HCl pH 8.0, 150 mM
NaCl, 1% NP-40, 1 mM phenylmethylsulfonylﬂuoride and protease
inhibitor cocktail) on ice for 30 min, centrifuged at 14000 g for 15 min
at 4 °C, and the supernatants were collected. Equal amounts of protein
from each sample were separated by SDS-PAGE and transferred to
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lowing incubation with antibodies against microtubule-associated pro-
tein 1 light-chain 3β (LC3β), p62, phospho-AMPKα (Thr172), AMPKα,
phospho-Raptor (Ser792), Raptor, phospho-mTOR (Ser2448), mTOR,
phospho-p70S6K (Thr389), p70S6K, phospho-p38 (Thr180/Tyr182), p38,
beclin-1, and β-actin (Cell Signaling Technology, Beverly, MA) as primary
antibodies and peroxidase-conjugated goat anti-rabbit IgG (Jackson IP
Laboratories, West Grove, PA) as a secondary antibody, speciﬁc protein
bands were visualized using enhanced chemiluminescence reagents for
Western blot analysis (Amersham Pharmacia Biotech, Piscataway, NJ).
The protein levels were quantiﬁed by densitometry using ImageJ
software and expressed relative to actin (LC3-II, beclin-1, p62) or
corresponding total protein signals (phospho-AMPK, phospho-mTOR,
phospho-Raptor, phospho-p70S6K, phospho-p38). The results are
presented as the fold change in signal intensity compared to that of
the untreated control at the same time-point, which was arbitrarily set
to 1.Fig 1. 6-Hydroxydopamine-induced apoptosis in SH-SY5Y cells is associated with oxidative
different concentrations of 6-OHDA and cell viability was determined after 24 h by crystal v
(50 μM) and cell morphology was examined by inverted microscopy after 24 h (D). Alternati
DHR (G) or DHE (H) and proportion of apoptotic (annexin+/PI−) cells (E), caspase activat
representative dot plots and histograms from at least three experiments are presented. The
experiments (*pb0.05 vs. untreated cells).2.7. RNA interference
The short hairpin RNA (shRNA) targeting human LC3β or AMPKα 1/2
genes, as well as scrambled control shRNA were obtained from Santa
Cruz Biotechnology (Santa Cruz, CA). SH-SY5Y cells in 6 well plates were
transfected with LC3β, AMPK or control shRNA according to the
manufacturer's protocol, using shRNA Plasmid Transfection Reagent
and Medium (Santa Cruz Biotechnology, Santa Cruz, CA). The stably
transfected cells were selected as recommended by the manufacturer
and maintained in selection medium containing puromycin (10 μg/ml).
Only the cells that have been propagated for less than eight passages
were used in the experiments.
2.8. Statistical analysis
The statistical signiﬁcance of the differences was analyzed by one-
way analysis of variance (ANOVA) followed by Student–Newman–stress and caspase activation. (A–C) SH-SY5Y cells were incubated in the presence of
iolet (A), MTT (B) and LDH test (C). (D–H) SH-SY5Y cells were incubated with 6-OHDA
vely, after 16 h of incubation cells were stained with annexin V-FITC/PI (E), ApoStat (F),
ion (F), ROS (G) or superoxide (H) production was examined by ﬂow cytometry. The
data are mean±SD values of triplicate measurements from a representative of three
Fig. 2. 6-OHDA induces autophagy in SH-SY5Y cells. (A–C) SH-SY5Y cells were incubated for 16 h in the presence of 50 μM (A, B) or different concentrations of 6-OHDA (C). The
presence of acridine orange (AO)-stained intracellular vesicles was demonstrated by ﬂuorescent microscopy (A) and ﬂow cytometry, showing an increase in red-to-green (FL3/FL1)
mean ﬂuorescence intensity (B, C). The data in (C) are mean±SD values from three independent experiments (*pb0.05 vs. untreated cells). (D) LC3 conversion, beclin-1 and p62
levels in SH-SY5Y cells treated with 6-OHDA (50 μM) were assessed by immunoblotting at the indicated time points. The blots from a representative of three experiments are
presented with the densitometry data above the relevant bands. (E) The TEM analysis of cells treated with 6-OHDA (50 μM) for 16 h showing intensive vacuolization (upper right
panel), double-membraned autophagosomes (lower left) and single-membraned autophagolysosomes containing cellular components (lower right).
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signiﬁcant.
3. Results
3.1. 6-Hydroxydopamine induces oxidative stress-mediated apoptotic
death of SH-SY5Y cells
The treatment with 6-OHDA for 24 h in a dose-dependent manner
reduced the viability of SH-SY5Y cells, as demonstrated by measuring
cell numbers, mitochondrial dehydrogenase activity and cell membrane
damage by crystal violet, MTT and LDH test, respectively (Fig. 1A–C).
The IC50 concentration was approximately 50 μM based on MTT and
crystal violet data, so this dose was chosen for further experiments.
Consistent with the induction of cell death, cells treated with 6-OHDA
lost their processes, became round, smaller and detached from the
culture well surface (Fig. 1D). The ﬂow cytometric analysis of the cells
stained with annexin V-FITC and propidium iodide has demonstrated
that 6-OHDA induced a signiﬁcant increase in numbers of early
apoptotic cells with intact cell membrane (annexin+/PI−), and only a
marginal increase in numbers of late apoptotic/necrotic cells
(annexin+/PI+) (Fig. 1E). 6-OHDA mediated apoptosis was associated
with activation of caspases, the principal apoptosis-executing enzymes
(Fig. 1F). The staining with the redox-sensitive ﬂuorochrome DHR and
the superoxide-selective DHE revealed that oxidopamine inducedFig. 3. 6-OHDA induced autophagy is associated with modulation of AMPK/mTOR signaling
mTOR signaling molecules was assessed by immunoblotting at the indicated time points. Th
data above the relevant bands. (B) Control shRNA- or AMPK shRNA-transfected cells were
cytometry after acridine orange (AO) staining (the insert shows immunoblot conﬁrmat
experiments (#pb0.05 vs. untreated control; *pb0.05 vs. 6-OHDA-treated control). (C) Cont
and the activation of AMPK/mTOR signaling molecules, LC3 conversion and p62 levels we
similar results are presented with the densitometry data above the relevant bands.oxidative stress, which could be at least partly attributed to the
superoxide production (Fig. 1G, H). Therefore, 6-OHDA induces oxidative
stress and caspase-dependent apoptosis in SH-SY5Y cells.
3.2. 6-Hydroxydopamine induces autophagy in SH-SY5Y cells
We next explored the ability of 6-OHDA to induce autophagy in
SH-SY5Y cells. Both ﬂuorescent microscopy and ﬂow cytometry demon-
strated an increase in acridine orange red ﬂuorescence in 6-OHDA-
treated SH-SY5Y cells (Fig. 2A–C), indicating the presence of intracellular
acidiﬁcation as one of the hallmarks of autophagic response. Accordingly,
immunoblot analysis revealed that 6-OHDA in a time-dependent
manner increased the conversion of LC3-I protein to its lipidated,
autophagosome-associated LC3-II form, while the expression of proau-
tophagic protein beclin-1 was only slightly upregulated (Fig. 2D). The
apparently low degree of LC3 conversion upon 6-OHDA treatment was
probably due to the fact that LC3-II increase is counteracted by its
simultaneous degradation in autophagolysosomes, and does not always
directly correspond to the extent of the autophagy induction [29].
However, the treatment with oxidopaminemarkedly decreased the level
of p62, a selective target for autophagic degradation [30], thus conﬁrming
the increase in autophagy-mediated proteolysis (Fig. 2D). Finally, the
induction of autophagy was conﬁrmed by ultrastructural TEM analysis,
showing extensive cytoplasmic vacuolization with many double-
membraned autophagosomes and single-membraned autolysosome-. (A) SH-SY5Y cells were incubated with 6-OHDA (50 μM) and the activation of AMPK/
e blots from a representative of three experiments are presented with the densitometry
treated with 6-OHDA for 16 h and the intracellular acidiﬁcation was analyzed by ﬂow
ion of AMPK knockdown). The data are mean±SD values from three independent
rol shRNA- or AMPK shRNA-transfected cells were treated with 6-OHDA (50 μM) for 8 h
re assessed by immunoblotting. The blots from one of at least two experiments with
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demonstrate that apoptosis coincideswith autophagy in 6-OHDA-treated
SH-SY5Y cells.
3.3. 6-OHDA induced autophagy depends on AMPK/mTOR signaling
To evaluate molecular mechanisms of 6-OHDA-mediated autophagy,
we analyzed the activation status of the main members of autophagy-
regulating AMPK/mTOR signaling pathway. The treatment with 6-OHDA
led to an increase in phosphorylation of AMPK and its direct downstream
target Raptor (Fig. 3A). The activation of AMPK/Raptor was associated
with the reduced phosphorylation of the major autophagy repressor
mTOR and its substrate S6K (Fig. 4A). The RNA interference-mediated
knockdownof AMPK expression prevented 6-OHDAmediated activation
of Raptor and subsequent mTOR/p70S6K inhibition, LC3 conversion, p62Fig. 4. Autophagy is involved in neurotoxicity of 6-OHDA. (A, B) SH-SY5Y cells were incubate
adenine (3-MA; 4 mM), wortmannin (Wort; 100 nM), baﬁlomycin A1 (Baf; 2 nM), NH4Cl
(A) and LDH release test (B). (C–I) SH-SY5Y cells transfected with control or LC3β shRN
knockdown). Intracellular acidiﬁcation (C), phosphatidylserine externalization (F), caspas
cytometry after 16 h. Cell viability was assessed by crystal violet (D) and LDH release te
representative of three experiments (A, B, D, E) or mean±SD values from three independ
control).degradation and intracellular acidiﬁcation (Fig. 3B, C). These data
indicate that AMPK-dependent mTOR inhibition is involved in
oxidopamine-stimulated autophagy in SH-SY5Y cells.
3.4. AMPK-dependent autophagy is involved in 6-OHDA neurotoxicity
To determine the role of autophagy in 6-OHDA toxicity towards
SH-SY5Y cells, we tested if the latter could be modulated by
inhibition or induction of autophagy. Pharmacological inhibitors of
autophagy, which block either class III phosphoinositide 3-kinase-
dependent formation of autophagosomes (wortmannin, 3-methyl
adenine) or formation/acidiﬁcation of autolysosomes (baﬁlomycin
A1, NH4Cl, chloroquine) [29], all markedly diminished 6-OHDA
induced cell damage (Fig. 4A, B). Accordingly, autophagy knock-
down with LC3β shRNA, conﬁrmed by ﬂow cytometric analysis ofd with 6-OHDA (50 μM) in the presence or absence of the autophagy inhibitors 3-methyl
(10 mM) and chloroquine (Cq; 20 μM). After 24 h, cell viability was assessed by MTT
A were treated with 6-OHDA (the inset in C shows immunoblot veriﬁcation of LC3β
e activation (G), ROS production (H) or superoxide levels (I) were examined by ﬂow
st (E) after 24 h. The data are mean±SD values of triplicate measurements from a
ent experiments (C, F–I) (p#b0.05 vs. untreated control; *pb0.05 vs. 6-OHDA-treated
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signiﬁcantly improved the viability of 6-OHDA-treated SH-SY5Y
cells (Fig. 4D, E). The protective effects of autophagy knockdown in
oxidopamine-treated neuroblastoma cells were associated with
the reduction in phosphatidylserine externalization (Fig. 4F),
caspase activation (Fig. 4G) and oxidative stress (Fig. 4H, I). Similar
results were obtained in AMPK shRNA-transfected SH-SY5Y cells
exposed to 6-OHDA, which displayed reduced cell death (Fig. 5A, B),
phosphatidylserine externalization (Fig. 5C), caspase activation (Fig. 5D)
and oxidative stress (Fig. 5E) in response to 6-OHDA. It should be noted
that, in accordance with the previous ﬁndings [31], AMPK-deﬁcient cells
displayed reduced proliferation rate, but the difference was not
signiﬁcant after 24 h. In contrast to AMPK knockdown, a well-known
mTOR inhibitor and autophagy inducer rapamycin [32] signiﬁcantlyFig. 5. AMPK/mTOR signaling is involved in neurotoxicity of 6-OHDA. (A–E) Control shRN
viability was assessed by crystal violet (A) or LDH test (B) after 24 h. Phosphatidylserine e
examined by ﬂow cytometry after 16 h. (F) SH-SY5Y cells were incubated with 6-OHDA
determined by MTT test after 24 h. The data are mean±SD values of triplicate measuremen
independent experiments (C–E) (p#b0.05 vs. untreated control; *pb0.05 vs. 6-OHDA-treatincreased 6-OHDA-induced death of SH-SY5Y cells (Fig. 5F), indicating a
role for mTOR inhibition in cytotoxic autophagy triggered by the
neurotoxin. Therefore, it appears that the AMPK/mTOR-dependent
induction of autophagy is involved in apoptotic demise of SH-SY5Y
cells upon oxidopamine treatment.
3.5. AMPK-dependent p38 activation mediates 6-OHDA neurotoxicity
independently of autophagy
Considering the important role of mitogen-activated protein kinase
(MAPK) family member p38 in 6-OHDA induced neurotoxicity [33], as
well as in autophagy induction by various agents [34,35], we next
investigated if p38MAPK is involved in oxidopamine stimulated cytotoxic
autophagy in SH-SY5Y cells. The treatment with 6-OHDA markedlyA- or AMPK shRNA-transfected SH-SY5Y cells were treated with 6-OHDA and the cell
xternalization (C), caspase activation (D) and ROS or superoxide production (E) were
(50 μM) in the presence or absence of rapamycin (RAP) and the cell viability was
ts from a representative of three experiments (A, B, F) or mean±SD values from three
ed control).
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cells, but not in AMPK-deﬁcient cells (Fig. 6A–C), despite the similar
efﬁciency of LC3 and AMPK knockdown (approx. 70% — not shown).
SB203580, the pharmacological p38 inhibitor that blocks its activity, but
not phosphorylation [36], signiﬁcantly reduced oxidopamine-induced
neuroblastoma cell killing (Fig. 6E, F). Treatment with SB203580 had no
effect on AMPK activity and LC3 conversion in 6-OHDA-exposed cells
(Fig. 6D). Therefore, it seems that AMPK-mediated activation of p38
MAPK contributes to the 6-OHDA neurotoxicity in an autophagy-
independent manner.
3.6. Oxidative stress is responsible for AMPK-mediated cytotoxic autophagy
and p38 activation
Oxidative stress has been implicated in 6-OHDA induced p38
activation and subsequent neurotoxicity [37], as well as in AMPK
phosphorylation in dopamine-treated neurons [38]. Accordingly, the
antioxidantN-acetyl cysteine,which efﬁciently reduced ROSproduction
(Fig. 7A), partly rescued neuroblastoma cells from 6-OHDA induced
cytotoxicity (Fig. 7B). In addition, NAC prevented oxidopamine-
stimulated activation of AMPK and p38 MAP kinase (Fig. 7C). Finally,
oxidative stress was involved in autophagy induction, as NAC reduced
6-OHDA-stimulated LC3 conversion and intracellular acidiﬁcation
(Fig. 7C, D). These data indicate that oxidative stress is involved in
oxidopamine-mediated AMPK activation and subsequent induction of
cytotoxic autophagy and p38 activation (Fig. 8).
4. Discussion
The present study demonstrates that neurotoxin 6-OHDA induces
autophagy in SH-SY5Y neuroblastoma cells through the oxidative
stress-dependent activation of intracellular energy sensor AMPK and
subsequent inhibition of the main autophagy repressor mTOR (Fig. 8).
Furthermore, we show that both AMPK-dependent autophagy, as wellFig. 6. AMPK/p38 signaling is involved in neurotoxicity of 6-OHDA. (A) SH-SY5Y cells we
immunoblotting at the indicated time points. (B, C) SH-SY5Y cells transfected with control s
8 h and p38 activation was determined by immunoblotting. (D–F) SH-SY5Y cells were inc
(10 μM). Phosphorylation of p38 and AMPK, as well as LC3 conversion were assessed by imm
(E) and LDH test (F) after 24 h of incubation. The representative blots are presented with t
values of triplicate measurements from a representative of three experiments (p#b0.05 vs.as AMPK-mediated autophagy-unrelated p38MAPK activation contrib-
ute to in vitro neurotoxicity of 6-OHDA (Fig. 8).
We assessed various autophagy endpoints, including LC3 conversion,
autophagosome and autolysosome formation, cytoplasmic acidiﬁcation
and p62 degradation, to demonstrate the induction of autophagic
response in neuroblastoma cells exposed to 6-OHDA. This is consistent
with the several recent studies that reported the ability of oxidopamine
to trigger autophagy in mouse and rat dopaminergic neurons [25–27] or
human neuroblastoma cells [24]. While it has previously been shown
that the induction of neuronal autophagy by 6-OHDA precursor
dopamine was associated with AMPK activation [38], no direct evidence
was provided for the involvement of AMPK in the observed autophagic
response. By combining RNA interference and pharmacological ap-
proach, we here conﬁrm that 6-OHDA-induced autophagy in human
neuroblastoma cells depends on the activation of AMPK/Raptor and
consequent inhibition of the negative autophagy regulator mTOR. The
expression of the proautophagic protein beclin-1 was only marginally
increased by 6-OHDA, consistentwith theﬁndings thatmTOR inhibition-
mediated autophagy can be beclin-independent [39]. Having in mind
that the activation of extracellular signal-regulated kinase (ERK) has
been implicated in autophagy induction by dopamine and neurotoxins
6-OHDA and MPP+ [24,40], we are currently investigating a possible
interplay between ERK and AMPK signaling in this process.
In accordance with the view that autophagy can promote
apoptosis in certain conditions [41,42], we here demonstrate that
AMPK/mTOR-dependent autophagy is partly responsible for the induc-
tion of oxidative stress leading to caspase activation and apoptotic death
in SH-SY5Y cells. To avoid possible off-target effects associated with the
autophagy-modulating strategies [30], we have used several pharmaco-
logical inhibitors that block either early (autophagosome formation) or
late (autolysosome formation) steps of the autophagic response, RNA
interference, as well as mTOR-blocking autophagy inducer rapamycin.
While it is still possible that some of the observed effects of autophagy
inhibitors, LC3 shRNA and rapamycin were autophagy-independent, our
data strongly argue in favor of the autophagy involvement in 6-OHDAre incubated with 6-OHDA (50 μM) and the phosphorylation of p38 was assessed by
hRNA (B, C), LC3 shRNA (B) or AMPK shRNA (C) were treated with 6-OHDA (50 μM) for
ubated with 6-OHDA (50 μM) in the presence or absence of p38 inhibitor SB 203580
unoblot after 8 h (D), while the cell viability was determined by crystal violet staining
he densitometry data above the relevant bands, while the data in (E, F) are mean±SD
untreated control; *pb0.05 vs. 6-OHDA-treated control).
Fig. 8. A hypothetical model of the autophagy-dependent and ‐independent mechanisms
of 6-OHDAneurotoxicity. Oxidative stress triggered by 6-OHDA causes activation of AMPK
and subsequent mTOR inhibition-dependent induction of autophagy, which further
promotes ROS production and contributes to apoptotic death of SH-SY5Y cells. On the
other hand, AMPK-mediated increase in p38 MAPK activation contributes to apoptosis in
an autophagy-independent manner.
Fig. 7. 6-OHDA induced oxidative stress is involved in AMPK-mediated cytotoxic autophagy and p38 activation. (A–D) SH-SY5Y cells were stimulated with 6-OHDA (50 μM) in the
presence or absence of N-acetyl cysteine (2 mM). After 16 h, ROS production followingDHR staining (A) and cellular acidiﬁcation in acridine orange (AO)-stained cells (D)were estimated
by ﬂow cytometry, while cell viability was determined by crystal violet test after 24 h (B). The data aremean±SDvalues from three independent experiments (A, D) ormean±SD values
of triplicatemeasurements froma representative of three experiments (B) (p#b0.05 vs. untreated control; *pb0.05 vs. 6-OHDA-treated control). (C) Phosphorylation of AMPK andp38, as
well as LC3 conversion were assessed by immunoblot after 8 h. The representative blots are presented with the densitometry data above the relevant bands.
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the autophagy blocker 3-methyladenine or conditional deletion of the
essential autophagy mediator Atg7 reduces 6-OHDA-triggered damage
of dopaminergic neurons in rats or mice, respectively [25,27]. In the
latter study, the neuroprotection was also achieved by enhancing the
activity of Akt/mTOR signaling axis, thus indirectly suggesting thatmTOR
inhibitionwas involved in neurotoxic effects of autophagy [27]. Our data
conﬁrm and extend these ﬁndings by directly demonstrating the crucial
role of AMPK as an upstream signal leading to the mTOR inhibition and
subsequent induction of autophagy and cell death in oxidopamine-
exposed neuronal cells. Interestingly, we have also observed that an
autophagy-independent arm of AMPK signaling, involving p38 MAPK
activation, could be involved in 6-OHDA neurotoxicity in vitro. This is in
line with the ability of AMPK to stimulate p38 activation in different
experimental settings [43,44], as well as with the known role of p38 in
oxidopamine neurotoxic action [33,37]. On the other hand, unlike the
results obtained here in 6-OHDA-exposed neuroblastoma cells, p38
MAPK contributed to autophagy induction in H2O2-treated ﬁbroblasts or
osteopontin-treated vascular smooth muscle cells [34,35], thus indicat-
ing a cell-speciﬁc and/or stimulus-speciﬁc effect.
Oxidative stress has a pivotal role in the induction of AMPK-
dependent autophagy by dopamine [38]. Accordingly, we here
demonstrated that oxidative stress was also responsible for the
activation of AMPK and autophagy by 6-OHDA. Moreover, ROS
production was responsible for AMPK-dependent phosphorylation of
p38 MAP kinase in our study, indicating that previously reported
involvement of oxidative stress in p38 activation by 6-OHDA [37] could
at least partly rely on AMPK as an intermediate signal. Therefore, it
seems that ROS production is both an effectormechanism of autophagic
cell demise, as well as a very proximal event responsible for the
initiation of AMPK-dependent autophagic response in 6-OHDAneurotoxicity. This is indeed consistent with the proposed involvement
of 6-OHDA auto-oxidation products, monoamine oxidase-dependent
H2O2 generation and delayed mitochondria-derived superoxide in the
induction of oxidative stress and subsequent neuronal death [2,45].
Finally, it should be noted that only partial neuroprotection was
achieved by inhibition of AMPK-dependent autophagy and p38 activation
in our study, as well as by autophagy inhibition in vivo [25,27], indicating
that some additional, AMPK-independentmechanisms, contribute to
6-OHDA neurotoxicity. There is also a question of the implications
1835K. Arsikin et al. / Biochimica et Biophysica Acta 1822 (2012) 1826–1836that our ﬁndings may possibly have for the pathogenesis of PD.
While the abnormal accumulation of autophagic vacuoles is evident
in the brains of PD patients [39,46], the exact role of autophagy in PD
is still unclear. The leading viewpoint is that autophagy may serve as
a protectivemachinery for degradation of the accumulatedα-synuclein
and dysfunctional mitochondria [47], but evidence to the contrary exist
[48]. This discrepancy could be timing-related, as it is conceivable that
while autophagy might be beneﬁcial as a clearing mechanism early in
the pathological process, its excessive activation may be deleterious
later on [49]. Thus, themodel of neurotoxin-induced autophagic demise
and here presented underlying mechanisms could be relevant for the
latter situation, as well as for the investigation of other neuronal insults
in which autophagy seems to play a destructive role [50].
In conclusion, the present report demonstrates that both autophagy-
dependent and -independent mechanisms are involved in the in vitro
neurotoxicity of oxidopamine. Both mechanisms are apparently con-
trolled by oxidative stress-activated AMPK, involving mTOR inhibition in
the former, and p38 MAPK activation in the latter neurotoxic pathway.
Therefore, AMPK-mediated autophagy and p38 activation might be valid
therapeutic targets for ﬁghting neurodegeneration and neurotoxicity.
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